CASP3 and monocytic leukemia: It was previously reported that ZVAD inhibited apoptosis but induced necroptosis, whereas Z-Asp-CH2-DCB (ZAsp)—a caspase inhibitor preferential to caspase-3—suppressed apoptosis without inducing necroptosis in TNF-treated U937 human monocytic leukemia cells [15].